Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8784844 | Advances in Radiation Oncology | 2018 | 11 Pages |
Abstract
Definitive hypofractionated radiation therapy using SABR and PBT appears to be dosimetrically feasible for the treatment of early stage breast cancer. The anatomical location of the tumor relative to the skin and chest wall appears to be the primary limiting dosimetric factor.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jonathan W. MD, Hao PhD, Michael C. MD, Lloyd D. CMD, Olusola MD, Shaan MD, Thomas P. MD, PhD, Sonali MD, Brian T. MD,